{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:40:45Z","timestamp":1790487645640,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T00:00:00Z","timestamp":1319500800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1038\/mp.2011.131","type":"journal-article","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T04:15:35Z","timestamp":1319516135000},"page":"67-78","source":"Crossref","is-referenced-by-count":228,"title":["Potential metabolite markers of schizophrenia"],"prefix":"10.1038","volume":"18","author":[{"given":"J","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,25]]},"reference":[{"key":"BFmp2011131_CR1","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1371\/journal.pmed.0020141","volume":"2","author":"S Saha","year":"2005","unstructured":"Saha S, Chant D, Welham J, McGrath J . A systematic review of the prevalence of schizophrenia. PLoS Med 2005; 2: e141.","journal-title":"PLoS Med"},{"key":"BFmp2011131_CR2","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMra035458","volume":"349","author":"R Freedman","year":"2003","unstructured":"Freedman R . Schizophrenia. N Engl J Med 2003; 349: 1738\u20131749.","journal-title":"N Engl J Med"},{"key":"BFmp2011131_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/schbul\/sbp017","volume":"35","author":"AW MacDonald","year":"2009","unstructured":"MacDonald AW, Schulz SC . What we know: findings that every theory of schizophrenia should explain. Schizophr Bull 2009; 35: 493\u2013508.","journal-title":"Schizophr Bull"},{"key":"BFmp2011131_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/archpsyc.59.10.921","volume":"59","author":"PD McGorry","year":"2002","unstructured":"McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59: 921\u2013928.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2011131_CR5","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1371\/journal.pmed.0030327","volume":"3","author":"E Holmes","year":"2006","unstructured":"Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW et al. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 2006; 3: e327.","journal-title":"PLoS Med"},{"key":"BFmp2011131_CR6","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1176\/ajp.2006.163.5.790","volume":"163","author":"TH McGlashan","year":"2006","unstructured":"McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006; 163: 790\u2013799.","journal-title":"Am J Psychiatry"},{"key":"BFmp2011131_CR7","first-page":"54","volume":"32","author":"DF Horrobin","year":"1980","unstructured":"Horrobin DF . Schizophrenia: a biochemical disorder? Biomedicine 1980; 32: 54\u201355.","journal-title":"Biomedicine"},{"key":"BFmp2011131_CR8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1742-1241.2001.tb11065.x","volume":"55","author":"BK Puri","year":"2001","unstructured":"Puri BK, Easton T, Das I, Kidane L, Richardson AJ . The niacin skin flush test in schizophrenia: a replication study. Int J Clin Pract 2001; 55: 368\u2013370.","journal-title":"Int J Clin Pract"},{"key":"BFmp2011131_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","volume":"61","author":"H Tavares","year":"2003","unstructured":"Tavares H, Yacubian J, Talib LL, Barbosa NR, Gattaz WF . Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophr Res 2003; 61: 1\u20136.","journal-title":"Schizophr Res"},{"key":"BFmp2011131_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.psychres.2005.10.010","volume":"143","author":"L Bosveld-van Haandel","year":"2006","unstructured":"Bosveld-van Haandel L, Knegtering R, Kluiter H, van den Bosch RJ . Niacin skin flushing in schizophrenic and depressed patients and healthy controls. Psychiatry Res 2006; 143: 303\u2013306.","journal-title":"Psychiatry Res"},{"key":"BFmp2011131_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jpsychores.2006.06.012","volume":"61","author":"MT Abou-Saleh","year":"2006","unstructured":"Abou-Saleh MT . Neuroimaging in psychiatry: an update. J Psychosom Res 2006; 61: 289\u2013293.","journal-title":"J Psychosom Res"},{"key":"BFmp2011131_CR12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","volume":"460","author":"H Stefansson","year":"2009","unstructured":"Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D et al. Common variants conferring risk of schizophrenia. Nature 2009; 460: 744\u2013747.","journal-title":"Nature"},{"key":"BFmp2011131_CR13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nature08192","volume":"460","author":"J Shi","year":"2009","unstructured":"Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe\u2019er I et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753\u2013757.","journal-title":"Nature"},{"key":"BFmp2011131_CR14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","volume":"460","author":"SM Purcell","year":"2009","unstructured":"Purcell SM, Wray NR, Stone JL, Visscher PM, O\u2019Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748\u2013752.","journal-title":"Nature"},{"key":"BFmp2011131_CR15","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.1021\/pr100904q","volume":"9","author":"PN Teng","year":"2010","unstructured":"Teng PN, Bateman NW, Hood BL, Conrads TP . Advances in proximal fluid proteomics for disease biomarker discovery. J Proteome Res 2010; 9: 6091\u20136100.","journal-title":"J Proteome Res"},{"key":"BFmp2011131_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1586\/14789450.5.1.21","volume":"5","author":"ML Cowan","year":"2008","unstructured":"Cowan ML, Vera J . Proteomics: advances in biomarker discovery. Expert Rev Proteomics 2008; 5: 21\u201323.","journal-title":"Expert Rev Proteomics"},{"key":"BFmp2011131_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/npp.2008.174","volume":"34","author":"R Kaddurah-Daouk","year":"2009","unstructured":"Kaddurah-Daouk R, Krishnan KR . Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 2009; 34: 173\u2013186.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2011131_CR18","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/004982599238047","volume":"29","author":"JK Nicholson","year":"1999","unstructured":"Nicholson JK, Lindon JC, Holmes E . \u2018Metabonomics\u2019: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181\u20131189.","journal-title":"Xenobiotica"},{"key":"BFmp2011131_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1159\/000199436","volume":"9","author":"NJ Zyromski","year":"2009","unstructured":"Zyromski NJ, Mathur A, Gowda GAN, Murphy C, Swartz-Basile DA, Wade TE et al. Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology. Pancreatology 2009; 9: 410\u2013419.","journal-title":"Pancreatology"},{"key":"BFmp2011131_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/0192623309332992","volume":"37","author":"KJ Boudonck","year":"2009","unstructured":"Boudonck KJ, Mitchell MW, N\u00e9met L, Keresztes L, Nyska A, Shinar D et al. Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol 2009; 37: 280\u2013292.","journal-title":"Toxicol Pathol"},{"key":"BFmp2011131_CR21","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/nature07762","volume":"457","author":"A Sreekumar","year":"2009","unstructured":"Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009; 457: 910\u2013914.","journal-title":"Nature"},{"key":"BFmp2011131_CR22","first-page":"1","volume-title":"Biomarkers for Psychiatric Disorders","author":"R Kaddurah-Daouk","year":"2009","unstructured":"Kaddurah-Daouk R, Soares JC, Quinones MP . Metabolomics: a global biochemical approach to the discovery of biomarkers for psychiatric disorders. In: Turck C (ed). Biomarkers for Psychiatric Disorders. Springer: New York, USA, 2009, pp 1\u201334."},{"key":"BFmp2011131_CR23","doi-asserted-by":"publisher","first-page":"R124","DOI":"10.1186\/gb-2008-9-8-r124","volume":"9","author":"P Khaitovich","year":"2008","unstructured":"Khaitovich P, Lockstone HE, Wayland MT, Tsang TM, Jayatilaka SD, Guo AJ et al. Metabolic changes in schizophrenia and human brain evolution. Genome Biol 2008; 9: R124.","journal-title":"Genome Biol"},{"key":"BFmp2011131_CR24","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/sj.mp.4001511","volume":"9","author":"S Prabakaran","year":"2004","unstructured":"Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684\u2013697, 643.","journal-title":"Mol Psychiatry"},{"key":"BFmp2011131_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","volume":"30","author":"DF Horrobin","year":"1998","unstructured":"Horrobin DF . The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 1998; 30: 193\u2013208.","journal-title":"Schizophr Res"},{"key":"BFmp2011131_CR26","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1021\/pr800188y","volume":"7","author":"E Schwarz","year":"2008","unstructured":"Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, Koethe D et al. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. J Proteome Res 2008; 7: 4266\u20134277.","journal-title":"J Proteome Res"},{"key":"BFmp2011131_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.nbd.2009.02.019","volume":"35","author":"MP Quinones","year":"2009","unstructured":"Quinones MP, Kaddurah-Daouk R . Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis 2009; 35: 165\u2013176.","journal-title":"Neurobiol Dis"},{"key":"BFmp2011131_CR28","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1371\/journal.pone.0000756","volume":"2","author":"JT Huang","year":"2007","unstructured":"Huang JT, Leweke FM, Tsang TM, Koethe D, Kranaster L, Gerth CW et al. CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS One 2007; 2: e756.","journal-title":"PLoS One"},{"key":"BFmp2011131_CR29","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1021\/pr0503782","volume":"5","author":"TM Tsang","year":"2006","unstructured":"Tsang TM, Huang JT, Holmes E, Bahn S . Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients. J Proteome Res 2006; 5: 756\u2013760.","journal-title":"J Proteome Res"},{"key":"BFmp2011131_CR30","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/sj.mp.4002000","volume":"12","author":"R Kaddurah-Daouk","year":"2007","unstructured":"Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM et al. Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry 2007; 12: 934\u2013945.","journal-title":"Mol Psychiatry"},{"key":"BFmp2011131_CR31","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/mp.2009.33","volume":"15","author":"JK Yao","year":"2010","unstructured":"Yao JK, Dougherty Jr GG, Reddy RD, Keshavan MS, Montrose DM, Matson WR et al. Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry 2010; 15: 938\u2013953.","journal-title":"Mol Psychiatry"},{"key":"BFmp2011131_CR32","doi-asserted-by":"publisher","first-page":"e9508","DOI":"10.1371\/journal.pone.0009508","volume":"5","author":"JK Yao","year":"2010","unstructured":"Yao JK, Dougherty Jr GG, Reddy RD, Keshavan MS, Montrose DM, Matson WR et al. Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naive patients with schizophrenia. PLoS One 2010; 5: e9508.","journal-title":"PLoS One"},{"key":"BFmp2011131_CR33","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1021\/pr9004162","volume":"8","author":"Y Qiu","year":"2009","unstructured":"Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y et al. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res 2009; 8: 4844\u20134850.","journal-title":"J Proteome Res"},{"key":"BFmp2011131_CR34","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1021\/ac0352427","volume":"76","author":"P Jonsson","year":"2004","unstructured":"Jonsson P, Gullberg J, Nordstrom A, Kusano M, Kowalczyk M, Sjostrom M et al. A strategy for identifying differences in large series of metabolomic samples analyzed by GC\/MS. Anal Chem 2004; 76: 1738\u20131745.","journal-title":"Anal Chem"},{"key":"BFmp2011131_CR35","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1021\/ac050601e","volume":"77","author":"P Jonsson","year":"2005","unstructured":"Jonsson P, Johansson AI, Gullberg J, Trygg J, A J, Grung B et al. High-throughput data analysis for detecting and identifying differences between samples in GC\/MS-based metabolomic analyses. Anal Chem 2005; 77: 5635\u20135642.","journal-title":"Anal Chem"},{"key":"BFmp2011131_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/11503415_34","volume-title":"Learning Theory","author":"P Golland","year":"2005","unstructured":"Golland P, Liang F, Mukherjee S, Panchenko D . Permutation tests for classification. In: Auer P, Meir R (eds). Learning Theory, vol. 3559, Springer: Berlin\/Heidelberg, 2005, pp 501\u2013515."},{"key":"BFmp2011131_CR37","first-page":"12","volume":"B57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser 1995; B57: 12.","journal-title":"J Roy Statist Soc Ser"},{"key":"BFmp2011131_CR38","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0031-3203(96)00142-2","volume":"30","author":"AP Bradley","year":"1997","unstructured":"Bradley AP . The use of the area under the ROC curve in the evaluation of machine learning algorithms. Pattern Recogn 1997; 30: 1145\u20131159.","journal-title":"Pattern Recogn"},{"key":"BFmp2011131_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.me.24.020173.001415","volume":"24","author":"L Sokoloff","year":"1973","unstructured":"Sokoloff L . Metabolism of ketone bodies by the brain. Annu Rev Med 1973; 24: 271\u2013280.","journal-title":"Annu Rev Med"},{"key":"BFmp2011131_CR40","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/oxfordjournals.schbul.a033381","volume":"25","author":"JW Newcomer","year":"1999","unstructured":"Newcomer JW, Craft S, Fucetola R, Moldin SO, Selke G, Paras L et al. Glucose-induced increase in memory performance in patients with schizophrenia. Schizophr Bull 1999; 25: 321\u2013335.","journal-title":"Schizophr Bull"},{"key":"BFmp2011131_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2350-9-39","volume":"9","author":"L Olsen","year":"2008","unstructured":"Olsen L, Hansen T, Jakobsen KD, Djurovic S, Melle I, Agartz I et al. The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples. BMC Med Genet 2008; 9: 39.","journal-title":"BMC Med Genet"},{"key":"BFmp2011131_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1176\/appi.ajp.161.2.305","volume":"161","author":"EA Hazlett","year":"2004","unstructured":"Hazlett EA, Buchsbaum MS, Kemether E, Bloom R, Platholi J, Brickman AM et al. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Am J Psychiatry 2004; 161: 305\u2013314.","journal-title":"Am J Psychiatry"},{"key":"BFmp2011131_CR43","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1089\/ars.2010.3459","volume":"15","author":"D Martins-de-Souza","year":"2011","unstructured":"Martins-de-Souza D, Harris LW, Guest PC, Bahn S . The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics. Antioxid Redox Signal 2011; 15: 2067\u20132079.","journal-title":"Antioxid Redox Signal"},{"key":"BFmp2011131_CR44","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/oxfordjournals.schbul.a033331","volume":"24","author":"MS Buchsbaum","year":"1998","unstructured":"Buchsbaum MS, Hazlett EA . Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull 1998; 24: 343\u2013364.","journal-title":"Schizophr Bull"},{"key":"BFmp2011131_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","volume":"160","author":"MC Ryan","year":"2003","unstructured":"Ryan MC, Collins P, Thakore JH . Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003; 160: 284\u2013289.","journal-title":"Am J Psychiatry"},{"key":"BFmp2011131_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","volume":"24","author":"LM Spelman","year":"2007","unstructured":"Spelman LM, Walsh PI, Sharifi N, Collins P, Thakore JH . Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia. Diabet Med 2007; 24: 481\u2013485.","journal-title":"Diabet Med"},{"key":"BFmp2011131_CR47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1192\/bjp.bp.108.052605","volume":"194","author":"E Fernandez-Egea","year":"2009","unstructured":"Fernandez-Egea E, Bernardo M, Donner T, Conget I, Parellada E, Justicia A et al. Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br J Psychiatry 2009; 194: 434\u2013438.","journal-title":"Br J Psychiatry"},{"key":"BFmp2011131_CR48","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1176\/ajp.2007.164.7.1072","volume":"164","author":"MS Buchsbaum","year":"2007","unstructured":"Buchsbaum MS, Buchsbaum BR, Hazlett EA, Haznedar MM, Newmark R, Tang CY et al. Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry 2007; 164: 1072\u20131081.","journal-title":"Am J Psychiatry"},{"key":"BFmp2011131_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.plefa.2006.02.001","volume":"74","author":"B Bu","year":"2006","unstructured":"Bu B, Ashwood P, Harvey D, King IB, Water JV, Jin LW . Fatty acid compositions of red blood cell phospholipids in children with autism. Prostaglandins Leukot Essent Fatty Acids 2006; 74: 215\u2013221.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"BFmp2011131_CR50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1146\/annurev.arplant.55.031903.141701","volume":"55","author":"K Apel","year":"2004","unstructured":"Apel K, Hirt H . Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol 2004; 55: 373\u2013399.","journal-title":"Annu Rev Plant Biol"},{"key":"BFmp2011131_CR51","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1515\/BC.2003.059","volume":"384","author":"R Dringen","year":"2003","unstructured":"Dringen R, Hirrlinger J . Glutathione pathways in the brain. Biol Chem 2003; 384: 505\u2013516.","journal-title":"Biol Chem"},{"key":"BFmp2011131_CR52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0165-6147(02)02060-6","volume":"23","author":"GJ McBean","year":"2002","unstructured":"McBean GJ . Cerebral cystine uptake: a tale of two transporters. Trends Pharmacol Sci 2002; 23: 299\u2013302.","journal-title":"Trends Pharmacol Sci"},{"key":"BFmp2011131_CR53","doi-asserted-by":"publisher","first-page":"e10883","DOI":"10.1371\/journal.pone.0010883","volume":"5","author":"WE Gall","year":"2010","unstructured":"Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ et al. Alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 2010; 5: e10883.","journal-title":"PLoS One"},{"issue":"Suppl","key":"BFmp2011131_CR54","doi-asserted-by":"publisher","first-page":"1016S","DOI":"10.1093\/jn\/130.4.1016S","volume":"130","author":"QR Smith","year":"2000","unstructured":"Smith QR . Transport of glutamate and other amino acids at the blood\u2013brain barrier. J Nutr 2000; 130 (Suppl): 1016S\u20131022S.","journal-title":"J Nutr"},{"key":"BFmp2011131_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0165-0173(90)90011-C","volume":"15","author":"JW McDonald","year":"1990","unstructured":"McDonald JW, Johnston MV . Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Brain Res Rev 1990; 15: 41\u201370.","journal-title":"Brain Res Brain Res Rev"},{"key":"BFmp2011131_CR56","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1471-4159.1975.tb04367.x","volume":"25","author":"AL Miller","year":"1975","unstructured":"Miller AL, Hawkins RA, Veech RL . Decreased rate of glucose utilization by rat brain in vivo after exposure to atmospheres containing high concentrations of CO2 . J Neurochem 1975; 25: 553\u2013558.","journal-title":"J Neurochem"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp2011131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2011131","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2011131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T14:40:07Z","timestamp":1686408007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2011131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,25]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["BFmp2011131"],"URL":"https:\/\/doi.org\/10.1038\/mp.2011.131","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,25]]}}}